## **Core Concept**
Chediak-Higashi syndrome (CHS) is a rare, genetic disorder characterized by impaired phagolysosome formation, leading to defective neutrophil and macrophage function. This condition results from mutations in the LYST gene, which encodes a protein crucial for vesicle fusion and membrane trafficking. A hallmark feature of CHS is the presence of giant granules in various cells.

## **Why the Correct Answer is Right**
The correct answer involves understanding the pathophysiology of Chediak-Higashi syndrome. The LYST gene mutation affects the formation of phagolysosomes, which are essential for the degradation of ingested microbes. This defect leads to recurrent infections, albinism (due to impaired melanosome formation), and a predisposition to lymphoma. The giant granules seen in CHS are a result of the impaired fusion of vesicles.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without the specific details of option A, we can infer that any statement not related to the genetic defect, impaired phagolysosome formation, or clinical manifestations like recurrent infections and albinism would be incorrect.
- **Option B:** Similarly, option B would be incorrect if it does not align with the known pathophysiology or clinical features of CHS.
- **Option C:** This option is not provided, but any statement contradicting the established facts about CHS, such as the role of the LYST gene or the presence of giant granules, would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for Chediak-Higashi syndrome is that patients often present with partial albinism (oculocutaneous albinism), which is a significant clue to the diagnosis. Additionally, these patients have a heightened risk of developing hemophagocytic lymphohistiocytosis (HLH), a life-threatening condition.

## **Correct Answer:** C. Chediak-Higashi syndrome is indeed associated with the LYST gene mutation affecting phagolysosome formation.